Volume 30, Number 6—June 2024
Synopsis
Severe Human Parainfluenza Virus Community- and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital, Seoul, South Korea, 2010–2019
Joung Ha Park1, Sang-Bum Hong1, Jin Won Huh, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Heungsup Sung, Kyung Hyun Do, Sung-Han Kim, Sang-Oh Lee, Yang Soo Kim, Chae-Man Lim, Younsuck Koh, and Sang-Ho Choi
Table 2
Co-infections of patients in study of severe human parainfluenza virus community- and healthcare-acquired pneumonia in adults at a tertiary hospital in Seoul, South Korea, 2010–2019*
| Co-pathogens† | Total, n = 143 | Community acquired, n = 80 | Hospital acquired, n = 63 | p value |
|---|---|---|---|---|
| Any |
78 (54.5) |
44 (55.0) |
34 (54.0) |
0.90 |
| Bacteria | 48 (33.6) | 32 (40.0) | 16 (25.4) | 0.07 |
| Gram positive | ||||
| Staphylococcus aureus | 8 | 4 | 4 | 0.73 |
| Streptococcus pneumoniae | 7 | 6 | 1 | 0.13 |
| Streptococcus pyogenes | 0 | 0 | 0 | NA |
| Streptococcus agalactiae | 0 | 0 | 0 | NA |
| Corynebacterium striatum |
1 |
0 |
1 |
0.44 |
| Gram negative | ||||
| Haemophilus influenzae | 1 | 1 | 0 | >0.99 |
| Moraxella catarrhalis | 0 | 0 | 0 | NA |
| Legionella sp. |
1 |
1 |
0 |
>0.99 |
| Enteric gram-negative bacilli | ||||
| Klebsiella pneumoniae | 8 | 7 | 1 | 0.08 |
| Escherichia coli | 2 | 2 | 0 | 0.50 |
| Enterobacter cloacae | 2 | 2 | 0 | 0.50 |
| Serratia marcescens | 1 | 1 | 0 | >0.99 |
| Enterobacter aerogenes |
1 |
1 |
0 |
>0.99 |
| Nonfermenting gram-negative bacilli | ||||
| Pseudomonas aeruginosa | 9 | 5 | 4 | 0.98 |
| Acinetobacter baumannii | 8 | 3 | 5 | 0.30 |
| Stenotrophomonas maltophilia |
1 |
0 |
1 |
0.44 |
| Viruses | 21 (14.7) | 12 (15.0) | 9 (14.3) | 0.90 |
| Rhinovirus | 6 | 5 | 1 | 0.23 |
| Respiratory syncytial virus | 5 | 2 | 3 | 0.65 |
| Adenovirus | 3 | 2 | 1 | >0.99 |
| Human coronavirus | 2 | 2 | 0 | 0.50 |
| Human metapneumovirus | 2 | 0 | 2 | 0.19 |
| Bocavirus | 2 | 0 | 2 | 0.19 |
| Influenza virus |
1 |
1 |
0 |
>0.99 |
| Fungi | 17 (11.9) | 4 (5.0) | 13 (20.6) | 0.004 |
| Aspergillus species | 15 | 3 | 12 | 0.003 |
| Pneumocystis jirovecii |
2 |
1 |
1 |
>0.99 |
| Nontuberculous mycobacteria | 1 (0.7) | 0 | 1 (1.6) | 0.44 |
*Values are no. (%) except as indicated. NA, not applicable. †Includes pathogens identified from bronchoalveolar lavage fluid or other specimens, such as nasopharyngeal, sputum, endotracheal aspirate, and blood culture samples during admission to the intensive care unit. Categories of co-infection were not mutually exclusive. Some cases were associated with >2 categories of pathogens.
1These authors contributed equally to this article.
Page created: April 19, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.